HOOK,HOOKIPA Pharma Inc. | Healthcare

Healthcare

HOOK

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

HOOKIPA Pharma Inc.HOOK

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform.

The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors.

Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers.

The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer.

HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus.

The company was incorporated in 2011 and is headquartered in New York, New York.

Latest News >

India vs South Africa 2nd Test: SA win by 7 wickets, level series 1-1

Jan 6, 2022

South Africa defeated India by seven wickets in the second Test to level the three-match series 1-1 on Thursday. India's bowlers could not extract enough from the surface with Mohammad Shami getting the only wicket to fall on the day. The third and final Test begins in Cape Town from January 11.

Funding Rundown: Reliance takes 26% stake in Dunzo for $200 mn, Bombay Shaving Company bags Rs 160 cr & Chalo eyeing $200 mn fundraise, says report

Jan 6, 2022

Here's a lowdown of the top deals from the startup space.

Coronavirus News highlights: Delta and Omicron variants spreading like 'tsunami', says TN health minister

Jan 5, 2022

Coronavirus Omicron India News LIVE Updates: The Indian Medical Association (IMA) requested the Centre and states to ensure that COVID duty of resident doctors do not exceed eight hours a day and after a week there should be a quarantine 10 to 14 day quarantine period in accommodation prescribed by the hospital. In the event of a Covid duty doctor falling ill, they should be hospitalised at the earliest. In a statement, the doctors' body said in case of untimely death, the status of COVID martyr and compensation as well as case-wise assistance should be arranged. There should also be a provision for taking care of the mental health of doctors, the IMA said. "Around 2,000 doctors died during the second wave of Covid. The mortality rate in the country was around 1.5 percent among the general population and around 2 to 3 percent among healthcare workers. According to this estimate, Covid occurred in about 1,00,000 doctors," the IMA said.

Australia agrees to delay Novak Djokovic's deportation; full hearing scheduled for January 10

Jan 6, 2022

World number one tennis player Novak Djokovic remained in Australia after his lawyers launched an appeal seeking to overturn the federal government decision. A court agreed not to deport him before a full hearing scheduled for Monday, leaving the Serbian champion holed up in a quarantine hotel in Melbourne for at least the next 72 hours.